Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SSRI Augmentation Could Increase Remission Rates As First-Line Therapy

Executive Summary

Augmentation of selective serotonin reuptake inhibitor initial therapy with another SSRI or other class of antidepressant agent could improve remission rates, authors of a study published in the March 23 New England Journal of Medicine suggested

You may also be interested in...

Antidepressant Switches, Add-On Therapy To Be Examined In AHRQ Study

The Agency for Healthcare Research and Quality is evaluating whether patients with depression experience better outcomes after switching antidepressants, or from addition of a second drug

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts